Introduction Aims
Kisspeptin-54 (KP54) is a recently identified hormone, which potently stimulates gonadotrophin releasing hormone (GnRH) secretion within the hypothalamus. Women with hypothalamic amenorrhoea (HA, hypogonadotrophic hypogonadism associated with low body weight) have reduced luteinising hormone (LH) pulsatility causing amenorrhea and infertility. We have previously demonstrated that exogenous administration of KP54 acutely stimulates gonadotrophin secretion in women with HA, but chronic administration results in tachyphylaxis. However, it is not known whether continuous exogenous administration of KP54 can stimulate LH pulsatility in women with HA.
To determine whether constant intravenous infusion of KP54 is able to stimulate pulsatile LH secretion in women with HA.
Kisspeptin-54 administration stimulates LH pulsatility in women with Hypothalamic Amenorrhoea 
Methods
In summary, we demonstrate for the first time that intravenous infusion of KP54 temporarily stimulates LH pulsatility in women with infertility due to HA. Furthermore we have determined that the dosing range of KP54 associated with pulsatile secretion of LH is distinct from higher doses of KP54 associated with tachyphylaxis. This work provides a basis for studying the potential of kisspeptin-based therapies to treat women with HA.
A single-blinded, placebo-controlled study was performed. Five participants with HA due to low body weight or exercise (mean BMI 18.3) each attended six study visits. Blood was sampled at 10min intervals for measurement of LH. Participants received a continuous intravenous infusion of vehicle or KP54 (doses 0.01, 0.03, 0.1, 0.3 or 1nmol/kg/h) for 8 hours. The 1nmol/kg/h dose was extended to 10h and immediately followed by a 100mcg GnRH test. LH pulsatility was determined by blinded deconvolution analysis. 
Summary and therapeutic implications
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During the highest dose of KP54 administration mean LH levels peaked at 5h after starting the infusion before gradually falling to levels 50% lower by the end of the 10h infusion when compared with peak levels. Mean LH secretion during a GnRH test immediately following infusion of the 1nmol/kg/h dose of KP54 and one week later was not significantly different suggesting that desensitisation to the stimulatory effects of KP54 did not involve the pituitary gland.
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